Publisher
source

Université de Caen Normandie

PhD in Cancer Biology Université de Caen Normandie in France

Degree Level

PhD

Field of study

Pharmacology

Funding

Available

Deadline

Nov 3, 2026

Country flag

Country

France

University

Université de Caen Normandie

Social connections

How do I apply for this?

Sign in for free to reveal details, requirements, and source links.

More information can be found here

Keywords

Pharmacology
Molecular Biology
Cancer Biology
Biology
Dna Repair
Pharmacy
Ovarian Cancer
Tumor Immunology
Combination Therapy
cancer immuonology

Suggested positions

About this position

PhD opportunity in cancer biology at Université de Caen Normandie and Inserm U1086 ANTICIPE, hosted at the François Baclesse Comprehensive Cancer Center in Caen, France.

The project focuses on the therapeutic potential of targeting UBE2N and its interplay with antitumor immunity in ovarian cancer. The research is designed to identify new therapeutic strategies by combining cancer and molecular biology, pharmacology, immuno-oncology, and patient-derived tumor organoid (PDTO) models.

The successful PhD student will work in a multidisciplinary translational environment with access to the ORGAPRED tumor organoid core facility and expertise in DNA repair, pharmacology, precision oncology, and tumor immunology. The position is offered for 36 months, with an expected start in January–February 2027.

Eligibility highlights: applicants should hold a Master’s degree or equivalent recognized in France/the EU, ideally in cancer biology, molecular/cellular biology, pharmacology, immunology, or a related field. A solid background in cancer biology, DNA repair, anticancer pharmacology, and mammalian cell culture is expected. Experience with functional assays, patient-derived tumor organoids, and immuno-oncology is considered an advantage. Good scientific English and the ability to work independently in a multidisciplinary team are important.

Application process: prepare a CV, academic transcripts, one reference letter or referee contact details, and a short motivation statement for joining the U-STING project. Submit the application by email to both supervisors. Deadline: 3 November 2026, 23:59 UTC.

This is a research-intensive PhD position in a strong clinical-translational cancer setting in Normandy, with opportunities to present at conferences and contribute to publications.

Funding details

Available

What's required

Applicants must hold a Master's degree or equivalent qualification recognized in France/the EU and allowing enrolment in a doctoral programme in France, preferably in cancer biology, molecular or cellular biology, pharmacology, immunology or a related discipline. A solid background in cancer biology and/or molecular and cellular biology is required, along with knowledge of DNA repair, anticancer pharmacology and/or therapeutic combinations, experience in mammalian cell culture, and good scientific English (written and spoken). Experience with functional assays, patient-derived tumor organoids, immuno-oncology, tumor–immune interactions or antitumor immune signaling is an advantage. Previous animal experimentation is not mandatory but would be an asset. The candidate should be able to work independently within a multidisciplinary team and be motivated to develop new experimental skills, project design, data analysis and scientific communication skills.

How to apply

Prepare a CV, master’s transcripts/academic records, and one reference letter or referee contact details. Write a brief motivation explaining your interest in the U-STING project and how your background fits the research. Email the application to both supervisors at [email protected] and [email protected].

Ask ApplyKite AI

Start chatting
Can you summarize this position?
What qualifications are required for this position?
How should I prepare my application?